NE-100, a novel sigma receptor ligand: In vivo tests
- 1 January 1993
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 53 (18) , PL285-PL290
- https://doi.org/10.1016/0024-3205(93)90588-t
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Neuropharmacological profile of a novel and selective ligand of the sigma site: SR 31742ANeuropharmacology, 1993
- Subchronic treatment of rats with remoxipride fails to modify σ binding sites in the brainEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Behavioural and biochemical evidence of the interaction of the putative antipsychotic agent, BMY 14802 with the 5-HT1A receptorEuropean Journal of Pharmacology, 1991
- Selective loss of cerebral cortical Sigma, but not PCP binding sites in schizophreniaBiological Psychiatry, 1991
- Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patientsPsychopharmacology, 1990
- Novel antipsychotic drugs share high affinity for σ receptorsEuropean Journal of Pharmacology, 1988
- Different effects of ethylketocyclazocine on phencyclidine- and N-allylnormetazocine-induced stereotyped behaviors in ratsPharmacology Biochemistry and Behavior, 1987
- Role of dopaminergic and serotonergic neuronal systems in the prefrontal cortex of rats in phencyclidine-induced behaviors.Journal of Pharmacobio-Dynamics, 1986
- Open label evaluation of the novel antipsychotic compound BW234U in chronic schizophrenicsDrug Development Research, 1985
- Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatumLife Sciences, 1984